These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 1322429)

  • 1. Effects of loperamide on the human hypothalamo-pituitary-adrenal axis in vivo and in vitro.
    Auernhammer CJ; Stalla GK; Lange M; Pfeiffer A; Müller OA
    J Clin Endocrinol Metab; 1992 Aug; 75(2):552-7. PubMed ID: 1322429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of repetitive administration of corticotropin-releasing hormone combined with lysine vasopressin on plasma adrenocorticotropin and cortisol levels in secondary adrenocortical insufficiency.
    Fukata J; Usui T; Tsukada T; Nakai Y; Koh T; Ishihara T; Tanaka I; Uchida K; Yoshimasa T; Nakano R
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1624-31. PubMed ID: 2172283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
    Dorin RI; Ferries LM; Roberts B; Qualls CR; Veldhuis JD; Lisansky EJ
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis.
    Trainer PJ; Faria M; Newell-Price J; Browne P; Kopelman P; Coy DH; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 1995 Feb; 80(2):412-7. PubMed ID: 7852498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's disease.
    Isidori AM; Kaltsas GA; Korbonits M; Pyle M; Gueorguiev M; Meinhardt A; Metz C; Petrovsky N; Popovic V; Bucala R; Grossman AB
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1834-40. PubMed ID: 11932327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of metyrapone pretreatment on adrenocorticotropin secretion induced by corticotropin-releasing hormone in normal subjects and patients with Cushing's disease.
    Totani Y; Niinomi M; Takatsuki K; Oiso Y; Tomita A
    J Clin Endocrinol Metab; 1990 Mar; 70(3):798-803. PubMed ID: 2155255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of somatostatin and octreotide to acutely affect the hypothalamic-pituitary-adrenal function in patients with corticotropin hypersecretion.
    Ambrosi B; Bochicchio D; Fadin C; Colombo P; Faglia G
    J Endocrinol Invest; 1990 Mar; 13(3):257-61. PubMed ID: 1973178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome.
    Demitrack MA; Dale JK; Straus SE; Laue L; Listwak SJ; Kruesi MJ; Chrousos GP; Gold PW
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1224-34. PubMed ID: 1659582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
    J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of atrial natriuretic factor infusion on basal and CRH-stimulated ACTH, cortisol and aldosterone levels in patients with Cushing's or Addison's disease.
    Ambrosi B; Sala C; Bochicchio D; Colombo P; Gazzano G; Fadin C; Morganti A; Faglia G
    Clin Endocrinol (Oxf); 1994 May; 40(5):589-94. PubMed ID: 8013139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
    Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F
    J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRH in Cushing's syndrome.
    Müller OA; Stalla GK; von Werder K
    Horm Metab Res Suppl; 1987; 16():51-8. PubMed ID: 2832289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
    Cleare AJ; Miell J; Heap E; Sookdeo S; Young L; Malhi GS; O'Keane V
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between the suppressive effects of dexamethasone and loperamide on cortisol and ACTH secretion in some pathological conditions.
    Bernini GP; Argenio GF; Cerri F; Franchi F
    J Endocrinol Invest; 1994 Nov; 17(10):799-804. PubMed ID: 7699214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute dexamethasone suppression of ACTH secretion stimulated by human corticotrophin releasing hormone, AVP and hypoglycaemia.
    Hohnloser J; Von Werder K; Müller OA
    Clin Endocrinol (Oxf); 1989 Aug; 31(2):175-84. PubMed ID: 2557988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
    Kumari M; Cover PO; Poyser RH; Buckingham JC
    Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In man the mu-opiate agonist loperamide specifically inhibits ACTH secretion induced by the cholecystokinin-like peptide ceruletide.
    Auernhammer CJ; Riepl RL; Schopohl J; Lehnert P; Müller OA; Stalla GK
    Neuroendocrinology; 1994 Jul; 60(1):16-22. PubMed ID: 8090278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis.
    Azziz R; Black V; Hines GA; Fox LM; Boots LR
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2317-23. PubMed ID: 9661602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.